Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @apeironbio
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @apeironbio
-
Peter Llewellyn-Davies (CEO) & Dr. Romana Gugenberger are looking forward to introduce you to
#ACellT, a new APEIRON Biologics spin-off, and their efforts to fight#rarecancer with#immunotherapy in San Francisco at#biotechshowcase and#jpm20.#cancer#celltherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
We are pleased to participate in the
#EMSO Congress 2019 in Barcelona! Poster: "1231P - Master Checkpoint Cbl-b Inhibition: Anti-tumor Efficacy in a Murine Colorectal Cancer Model Following siRNA-based Cell Therapy" Poster Display Session 3, 12pm-1pm, today; Poster Area Hall 4pic.twitter.com/xmoodaDp8j
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
APEIRON Biologics AG proslijedio/la je Tweet
#ESMO19: all released abstracts now available online on OncologyPRO
All are open access & searchable by title/author http://ow.ly/tt6D50wm262 @AndresC27622123@jeanyvesblay@EACRnews@cancernurseEUpic.twitter.com/80zQPA97uI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
APEIRON Biologics AG presents in two important scientific meetings in September 2019:
#BASELLIFE19#ESMO19https://www.linkedin.com/posts/apeiron-biologics_basellife19-esmo19-activity-6579394637604114432-cEDJ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Everything you do with passion will succeed.https://twitter.com/Labiotech_eu/status/1152828064327458816 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A story like this makes us particularly proud to be the first Austrian company to launch Qarziba, an
#immunotherapy drug, together with Professor Holger Lodge. https://bit.ly/2GpFYuP#neuroblastom#cancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
APEIRON Biologics is one of the presenting companies at
#BioEquity in Barcelona. CEO@PLD_ reports this afternoon to the interested audience about the current developments at@apeironbio.@BioCentury@EBDgrouppic.twitter.com/dPfI6oOyut
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
APEIRON Biologics AG proslijedio/la je Tweet
20th
#BioEquity Europe: Today, Europe's partnering conference for dealmakers and investor-validated life science companies opened its doors in#Barcelona to discuss#hottopics,#hotspots. Check out the event's program https://bit.ly/2SMuPMI pic.twitter.com/lq0h0a09Ck
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A warm welcome to the guests of Bio€quity 2019 in Barcelona!
#BioEquitypic.twitter.com/iUPjy4uRo5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CEO Peter Llewellyn-Davies
@PLD_ will attend#BioEquity Europe in Barcelona and present the latest developments of APEIRON Biologics. We look forward to meeting you there.@BioCentury@EBDgrouppic.twitter.com/PNr8viYCwW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A nice get-together!

Thanks to Austrian Marshall Plan Foundation and Advantage Austria @Austria_in_US for the great organisation.https://www.linkedin.com/feed/update/urn:li:activity:6534346857999552512 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Meet the CEO of APEIRON Biologics Peter Llewellyn-Davies
@PLD_ at#BioEquity 2019 and learn more about the company at first hand.https://twitter.com/BioCentury/status/1126147260075712514 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
APEIRON Biologics AG proslijedio/la je Tweet
Great list, love the bonus episode - Top 10 Biotech Podcasts You Should Listen to this Spring https://buff.ly/2GyG8PQ
#biotech#podcast@theFuturelabs@a16z@statnews via@Labiotech_eupic.twitter.com/owb8QsWcot
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It was nice to be part of the Swiss Biotech Day 2019!
#SBD2019 See you next time!pic.twitter.com/se6VLgpvfa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CMO & CSO Anderson Gaweco, M.D., PhD, is currently speaking in Panel 2 "Cell-based Therapeutics" at Swiss Biotech Day 2019: Master Checkpoint Cbl-b Inhibition - Ambulatory siRNA-Based Autologous Cell Therapy for Cancer
#sbd2019Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
APEIRON would like to extend their sincerest thanks to the Oncology Leadership at
@bswhealth Cancer Center in Dallas, TX.#immunotherapy#Cancerhttps://www.linkedin.com/feed/update/urn:li:activity:6526774965356756992 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
APEIRON Biologics AG proslijedio/la je Tweet
One of my favorite biotech keynote - What Does the Future Hold for European Biotech? Insights from Evotec’s CEO Werner Lanthaler https://buff.ly/2Gt1kYC
@Evotec#BIOEuropeSpring@EBDgrouppic.twitter.com/c4nYqlD9ta
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Please join our Chief Medical Officer & Chief Scientific Officer Anderson Gaweco, MD, PhD, who will speak at the invitation of Daniel D. Von Hoff, MD, FACP, FASCO, FAACR and Carlos Becerra at the
@bswhealth Research Institute on "Master Checkpoint Cbl-b Inhibition"pic.twitter.com/vh6DKe1uPP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The scientific program of the
#ITOC6 in#vienna with an international faculty has focused on the most relevant topics of#Immunotherapy of#cancer. Congratulations to the Conference Presidents@cczielinski and@MSznolpic.twitter.com/AVu4EVgOkJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.